It seems that the Board of NBN Co has managed to become a favorite haunt of ex-McKinsey management, with a third director from the consultancy firm coming in take a place in the newly appointed leaders.

A former Director of McKinsey has now become one of the two new appointments on the Board of NBN Co, which has been given the task of building the Federal Government's $43 Billion fiber to effectively carry out the project of providing the country with a high speed broadband network.

Incitec Pivot, the fertilizer and chemical business today confirmed that all businesses under its wings have managed to perform in-line with the expectation pegged since the last fiscal year ended for the firm.

However, the firm did say that it was still too early to get any strong hints as to how the performance will be for the current financial year.

Talks between Chinese state-backed chemicals trading business, Sinochem and Australia’s largest agricultural chemical manufacturer, Nufarm Ltd. seem to have reached a stalemate. The Chinese company was looking towards Nufarm to become a global company in the crop protection industry. The initial offer by Sinochem was subsequently cut down by nearly 8 percent and now stands at A$2.6bn (US$2.3bn).

Fisher & Paykel Healthcare is set to open a new multi-million dollar facility in Auckland, tender process for which is already undergoing. Its exact cost would be clear after the completion of the tendering process but it would be more than the amount spent on its previous building.

The upcoming building in 30,000sq m area is aimed to satisfy the growing demand in the healthcare segment.

It is being speculated that the main reason why NAB is closing in on AXA Asia Pacific is because the "Australian superannuation and savings industry" might be going in for some very significant fundamental changes.

The amount of fees charged will be going down on the back of new regulations, and the industry will make the most of the high income products which are currently at the top of the market and popular mass products for the remaining bulk of the sector.

It is being speculated that the main reason why NAB is closing in on AXA Asia Pacific is because the "Australian superannuation and savings industry" might be going in for some very significant fundamental changes.

The amount of fees charged will be going down on the back of new regulations, and the industry will make the most of the high income products which are currently at the top of the market and popular mass products for the remaining bulk of the sector.